股神经持续阻滞与静脉注射帕瑞昔布联合治疗全膝关节置换术后疼痛的血流动力学、副作用和安全性:试点研究。

IF 1.4 Q3 ORTHOPEDICS
Orthopedic Reviews Pub Date : 2024-09-14 eCollection Date: 2024-01-01 DOI:10.52965/001c.122536
Despoina Sarridou, Anna Gkiouliava, Helena Argiriadou, Aikaterini Amaniti, Georgia Chalmouki, Athina Vadalouka
{"title":"股神经持续阻滞与静脉注射帕瑞昔布联合治疗全膝关节置换术后疼痛的血流动力学、副作用和安全性:试点研究。","authors":"Despoina Sarridou, Anna Gkiouliava, Helena Argiriadou, Aikaterini Amaniti, Georgia Chalmouki, Athina Vadalouka","doi":"10.52965/001c.122536","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Total Knee Arthroplasty (TKA) is a well-established surgical procedure for the treatment of knee joint diseases. This operation leads to severe acute and chronic pain, and intravenous administration of parecoxib could provide significant pain relief.</p><p><strong>Objective: </strong>The aim of the study was to compare the hemodynamic data and safety profile of patients who received parecoxib compared to placebo following TKA.</p><p><strong>Methods: </strong>Ninety patients were followed during this study and were randomly assigned into two equal groups. Group P received parecoxib and Group C received the placebo. Exclusion criteria included age < 40 or > 80 years, ASA III or higher, obesity (>140 kg), allergy to local anaesthetics, opioid dependence, contraindications for subarachnoid anaesthesia, femoral block or the administration of parecoxib.The haemodynamic data collected were Systolic Arterial Pressure (SAP), Diastolic Arterial Pressure (DAP), Heart Rate (HR), Oxygen Saturation (Ox-Sat), blood transfusion requirements and side effects. Recordings were performed every hour for up to 10 hours and at 15min, 4, 8, 12, 24, 36 hours postoperatively.</p><p><strong>Results: </strong>The postoperative SAP and DAP data presented similar findings among groups (p>0.05) within the aforementioned time intervals. The postoperative HR data for both groups displayed no statistically significant difference between the two cohorts (p>0.05). Regarding the occurrence of transfusion, there is no statistically significant difference between the parecoxib and placebo cohorts. The frequency of side effects was negligible and could not be correlated with either group.</p><p><strong>Conclusion: </strong>Therefore, parecoxib did not render any noticeable impact on the hemodynamic profile of the patients.</p>","PeriodicalId":19669,"journal":{"name":"Orthopedic Reviews","volume":"16 ","pages":"122536"},"PeriodicalIF":1.4000,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11405027/pdf/","citationCount":"0","resultStr":"{\"title\":\"Haemodynamics, side effects and safety of the combination of continuous femoral nerve block and intravenous parecoxib for pain management after Total Knee Arthroplasty: A pilot study.\",\"authors\":\"Despoina Sarridou, Anna Gkiouliava, Helena Argiriadou, Aikaterini Amaniti, Georgia Chalmouki, Athina Vadalouka\",\"doi\":\"10.52965/001c.122536\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Total Knee Arthroplasty (TKA) is a well-established surgical procedure for the treatment of knee joint diseases. This operation leads to severe acute and chronic pain, and intravenous administration of parecoxib could provide significant pain relief.</p><p><strong>Objective: </strong>The aim of the study was to compare the hemodynamic data and safety profile of patients who received parecoxib compared to placebo following TKA.</p><p><strong>Methods: </strong>Ninety patients were followed during this study and were randomly assigned into two equal groups. Group P received parecoxib and Group C received the placebo. Exclusion criteria included age < 40 or > 80 years, ASA III or higher, obesity (>140 kg), allergy to local anaesthetics, opioid dependence, contraindications for subarachnoid anaesthesia, femoral block or the administration of parecoxib.The haemodynamic data collected were Systolic Arterial Pressure (SAP), Diastolic Arterial Pressure (DAP), Heart Rate (HR), Oxygen Saturation (Ox-Sat), blood transfusion requirements and side effects. Recordings were performed every hour for up to 10 hours and at 15min, 4, 8, 12, 24, 36 hours postoperatively.</p><p><strong>Results: </strong>The postoperative SAP and DAP data presented similar findings among groups (p>0.05) within the aforementioned time intervals. The postoperative HR data for both groups displayed no statistically significant difference between the two cohorts (p>0.05). Regarding the occurrence of transfusion, there is no statistically significant difference between the parecoxib and placebo cohorts. The frequency of side effects was negligible and could not be correlated with either group.</p><p><strong>Conclusion: </strong>Therefore, parecoxib did not render any noticeable impact on the hemodynamic profile of the patients.</p>\",\"PeriodicalId\":19669,\"journal\":{\"name\":\"Orthopedic Reviews\",\"volume\":\"16 \",\"pages\":\"122536\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2024-09-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11405027/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Orthopedic Reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52965/001c.122536\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"ORTHOPEDICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Orthopedic Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52965/001c.122536","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0

摘要

背景:全膝关节置换术(TKA)是一种治疗膝关节疾病的成熟手术方法。该手术会导致严重的急性和慢性疼痛,而静脉注射帕瑞昔布可明显缓解疼痛:研究旨在比较接受帕瑞昔布与安慰剂治疗的膝关节置换术患者的血液动力学数据和安全性:在这项研究中,对 90 名患者进行了随访,并将他们随机分配到两个相同的组别。P组接受帕瑞昔布治疗,C组接受安慰剂治疗。排除标准包括年龄小于 40 岁或大于 80 岁、ASA III 级或更高、肥胖(大于 140 公斤)、对局麻药过敏、阿片类药物依赖、蛛网膜下腔麻醉禁忌症、股骨阻滞或服用帕瑞昔布。收集的血液动力学数据包括收缩压(SAP)、舒张压(DAP)、心率(HR)、血氧饱和度(Ox-Sat)、输血需求和副作用。术后 10 小时内每小时记录一次,术后 15 分钟、4、8、12、24、36 小时记录一次:在上述时间间隔内,各组的术后 SAP 和 DAP 数据结果相似(P>0.05)。两组的术后 HR 数据在统计学上无显著差异(P>0.05)。在输血发生率方面,帕瑞昔布组和安慰剂组之间没有统计学意义上的显著差异。结论:帕瑞昔布和安慰剂组的副作用发生率几乎可以忽略不计,且与两组均无相关性:因此,帕瑞昔布对患者的血液动力学状况没有明显影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Haemodynamics, side effects and safety of the combination of continuous femoral nerve block and intravenous parecoxib for pain management after Total Knee Arthroplasty: A pilot study.

Background: Total Knee Arthroplasty (TKA) is a well-established surgical procedure for the treatment of knee joint diseases. This operation leads to severe acute and chronic pain, and intravenous administration of parecoxib could provide significant pain relief.

Objective: The aim of the study was to compare the hemodynamic data and safety profile of patients who received parecoxib compared to placebo following TKA.

Methods: Ninety patients were followed during this study and were randomly assigned into two equal groups. Group P received parecoxib and Group C received the placebo. Exclusion criteria included age < 40 or > 80 years, ASA III or higher, obesity (>140 kg), allergy to local anaesthetics, opioid dependence, contraindications for subarachnoid anaesthesia, femoral block or the administration of parecoxib.The haemodynamic data collected were Systolic Arterial Pressure (SAP), Diastolic Arterial Pressure (DAP), Heart Rate (HR), Oxygen Saturation (Ox-Sat), blood transfusion requirements and side effects. Recordings were performed every hour for up to 10 hours and at 15min, 4, 8, 12, 24, 36 hours postoperatively.

Results: The postoperative SAP and DAP data presented similar findings among groups (p>0.05) within the aforementioned time intervals. The postoperative HR data for both groups displayed no statistically significant difference between the two cohorts (p>0.05). Regarding the occurrence of transfusion, there is no statistically significant difference between the parecoxib and placebo cohorts. The frequency of side effects was negligible and could not be correlated with either group.

Conclusion: Therefore, parecoxib did not render any noticeable impact on the hemodynamic profile of the patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Orthopedic Reviews
Orthopedic Reviews ORTHOPEDICS-
CiteScore
2.70
自引率
4.80%
发文量
122
审稿时长
10 weeks
期刊介绍: Orthopedic Reviews is an Open Access, online-only, peer-reviewed journal that considers articles concerned with any aspect of orthopedics, as well as diagnosis and treatment, trauma, surgical procedures, arthroscopy, sports medicine, rehabilitation, pediatric and geriatric orthopedics. All bone-related molecular and cell biology, genetics, pathophysiology and epidemiology papers are also welcome. The journal publishes original articles, brief reports, reviews and case reports of general interest.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信